Loading...
Market
Will Walgreens complete the BARDA Project NextGen COVID-19 clinical study by December 31, 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcement from Walgreens or HHS
Story
HHS Announces Walgreens' BARDA Award for COVID-19 Decentralized Clinical Study Under Project NextGen
Jul 23, 2024, 01:01 PM
Walgreens has received the BARDA Project NextGen Award to conduct a novel COVID-19 decentralized clinical study. The study, which is part of a Phase IV trial, will be carried out in partnership with the RRPV Consortium and will focus on a US FDA authorized or approved COVID-19 vaccine. The trial aims to identify correlates of protection for COVID vaccines and will take place at approximately 20 Walgreens sites, ranging from urban to rural locations. HHS announces the pharmacy-based clinical trial under Project NextGen.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
